Arcalyst

Active Ingredient(s): Rilonacept
FDA Approved: * February 27, 2008
Pharm Company: * REGENERON PHARMACEUTICALS
Category: Anti-Inflammatory

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Arcalyst Overview

Rilonacept, also known as IL-1 Trap (marketed by Regeneron Pharmaceuticals under the trade name Arcalyst), is an interleukin 1 inhibitor.[1] Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component (IL-1R1) and IL-1 receptor accessory protein (IL-1RAcP) linked in-line to the fragment-crystallizable portion (Fc region) of human IgG1 that binds and neutralizes IL-1.[2&#...

Read more Arcalyst Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rilonacept

Recent Arcalyst Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rilonacept
  • Vial: 220mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Arcalyst: (1 result)

Sorted by National Drug Code
  • 61755-001 Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Regeneron Pharmaceuticals, Inc.

Other drugs which contain Rilonacept or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA